Long-Term Liabilities to Equity: Embecta Health (EMBC)

Official company branding of Embecta Health (EMBC)

This chart of Embecta Corp. (EMBC) stock quotes illustrates the dynamics of a leader in the insulin delivery systems segment, whose success is based on global reach and low production costs. The company's dominance is reinforced by strict regulatory control and massive production capacities, making entry for new players virtually impossible. The current indicator stands at 0.00, while the business relies on a closed ecosystem where high patient loyalty to consumables limits the switching of therapies.

Embecta Inc. (EMBC): Long-Term Debt to Capital from 04/28/2023 to 10/27/2026

Comprehensive metric breakdowns and analytics for Embecta Corp. (EMBC)

- price and consensus price forecast:
Market Chart Embecta Corp|EMBC - Price Target Chart
- market capitalization data:
Market Valuation Embecta Corp.|EMBC - Enterprise Value
- book capitalization data:
Net Asset Value per Share Embecta|EMBC - Book Capitalization|Market Cap to Net Assets Ratio embecta.com|EMBC - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Embecta Corp.|EMBC - Long-Term Debt to Capital|Short-Term Debt to Capital embecta.com|EMBC - Company Debts|Debt to Book Capitalization Ratio Embecta Corp.
Comprehensive company analysis:EMBC, Embecta Corp
Core merchandise of Embecta Corp.

Professional capital assesses the financial stability of Embecta Corp. (EMBC) by analyzing the balance between borrowed funds and equity resources used to develop sustainable plastic recycling initiatives. This long-term debt-to-equity ratio measures the proportion of loans with maturities exceeding one year within the capital structure, allowing investors to identify solvency risks in a timely manner and determine the overall reliability of the asset.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital AORT|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity Integra LifeSciences Corp (IART)|Long-Term Debt to Capital ESTA|BBNX - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio IRADIMED CORPORATION|TNDM - Long-Term Liabilities to Equity|Long-Term Debt to Capital AXGN|SI-BONE Inc (SIBN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital Orthofix International (OFIX)|Long-Term Debt to Capital Ratio Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient TMCI (treace.com)|Strata Critical Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Carlsmed, Inc. CARL|RXST (RxSight Corp) - Long-Term Debt to Capital|CLPT - Long-Term Liabilities to Capital|Long-Term Debt to Capital Stereotaxis, Inc.|neurostar.com (STIM) - Long-Term Debt to Capital Ratio|SGHT: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Orchestra BioMed Inc.|Long-Term Debt to Capital ANIK (Anika Therapeutics)|Long-Term Debt to Equity Ratio InspireMD Inc. (NSPR)|Long-Term Debt to Capital ZJYL (Jin Medical)|Vivani Medical Inc - Long-Term Debt to Capital|XTNT - Long-Term Debt to Equity|NeuroOne (NMTC) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio modular-medical.com MODD|Myomo Inc (MYO) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital COCH (Envoy Medical, Inc.)|Long-Term Liabilities to Capital VVOS|NVNO: Long-Term Debt to Equity|Long-Term Indebtedness to Equity sintx.com SINT|Long-Term Debt to Equity Ratio TNON (Tenon Medical, Inc)|Long-Term Debt to Capital Lifeward Ltd. LFWD|Long-Term Debt to Capital AMIX (Autonomix)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)